Previously this was on doubts of the penetration of the US market though, once that was firmed up we saw the run into the 90s. Could well drop more, but shouldn't be that savage.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025